References
- Bartholin L, Wessner LL, Chirgwin JM, Guise TA (2007). The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett, 246, 230-6. https://doi.org/10.1016/j.canlet.2006.02.019
- Baum B, Settleman J, Quinlan MP (2008). Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol, 19, 294-308. https://doi.org/10.1016/j.semcdb.2008.02.001
- Bleau AM, Planque N, Perbal B (2005). CCN proteins and cancer: two to tango. Front Biosci, 10, 998-1009. https://doi.org/10.2741/1594
- Chen C, Zimmermann M, Tinhofer I, Kaufmann AM, Albers AE (2013). Epithelial-to-mesenchymal transition and cancer stem (-like) cells in head and neck squamous cell carcinoma. Cancer Lett, 338, 47-56. https://doi.org/10.1016/j.canlet.2012.06.013
- Chen CC, Lau LF (2009). Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol, 41, 771-83. https://doi.org/10.1016/j.biocel.2008.07.025
- Chien W, Kumagai T, Miller CW, et al (2004). Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem, 279, 53087-96. https://doi.org/10.1074/jbc.M410254200
- Cichon MA, Radisky DC (2014). Extracellular matrix as a contextual determinant of transforming growth factor-b signaling in epithelial-mesenchymal transition and in cancer. Cell Adh Migr, 8, 588-94. https://doi.org/10.4161/19336918.2014.972788
- Crockett JC, Schutze N, Tosh D, et al (2007). The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology, 148, 5761-8. https://doi.org/10.1210/en.2007-0473
- Dhar A, Ray A (2010). The CCN family proteins in carcinogenesis. Exp Oncol, 32, 2-9.
- Genini M, Schwalbe P, Scholl FA, Schafer BW (1996). Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma. Int J Cancer, 66, 571-7. https://doi.org/10.1002/(SICI)1097-0215(19960516)66:4<571::AID-IJC24>3.0.CO;2-9
- Grant CM, Kyprianou N (2013). Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression. Transl Androl Urol, 2, 202-11.
- Hou CH, Lin FL, Hou SM, Liu JF (2014). Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol Cancer, 13, 236. https://doi.org/10.1186/1476-4598-13-236
-
Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012). The matrix protein CCN1/CYR61 is required for
${\alpha}\;(V){\beta}5$ -mediated cancer cell migration. Cell Biochem Funct, 30, 687-95. https://doi.org/10.1002/cbf.2853 -
Juric V, Chen CC, Lau LF (2012).
$TNF{\alpha}$ -induced apoptosis enabled by CCN1/CYR61: pathways of reactive oxygen species generation and cytochrome c release. PLoS One, 7, 31303 https://doi.org/10.1371/journal.pone.0031303 - Lau LF, Nathans D (1985). Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J, 4, 3145-51.
- Lau LF (2011). CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci, 68, 3149-63. https://doi.org/10.1007/s00018-011-0778-3
- Leu SJ, Chen N, Chen CC, et al (2004). Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions. J Biol Chem, 279, 44177-87. https://doi.org/10.1074/jbc.M407850200
- Lin CM, Liang CZ (2014). Cyr61: a potential therapeutic target for prostate cancer. Asian J Androl, 16, 788-9. https://doi.org/10.4103/1008-682X.128517
-
Lu JG, Li Y, Li L, Kan X (2011). Overexpression of osteopontin and integrin
${\alpha}v$ in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis. J Cancer Res Clin Oncol, 137, 1613-8. https://doi.org/10.1007/s00432-011-1024-y - Maity G, Mehta S, Haque I, et al (2014). Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization. Sci Rep, 4, 4995.
- Menendez JA, Vellon L, Mehmi I, et al (2005). A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene, 24, 761-79. https://doi.org/10.1038/sj.onc.1208238
- Monnier Y, Farmer P, Bieler G, et al (2008). CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res, 68, 7323-31. https://doi.org/10.1158/0008-5472.CAN-08-0841
- Mori A, Desmond JC, Komatsu N, et al (2007). CYR61: a new measure of lung cancer outcome. Cancer Invest, 25, 738-41. https://doi.org/10.1080/02770900701512597
-
Roth P, Silginer M, Goodman SL, et al (2013). Integrin control of the transforming growth factor-
${\beta}$ pathway in glioblastoma. Brain, 136, 564-76. https://doi.org/10.1093/brain/aws351 - Sampath D, Zhu Y, Winneker RC, Zhang Z (2001). Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab, 86, 1707-15.
- Schmitz P, Gerber U, Schutze N, et al (2013). Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4. Thromb Haemost, 110, 1046-54. https://doi.org/10.1160/TH13-02-0158
- Sin WC, Bechberger JF, Rushlow WJ, Naus CC (2008). Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J Cell Biochem, 103, 1772-82. https://doi.org/10.1002/jcb.21571
- Su JL, Chiou J, Tang CH, et al (2010). CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem, 285, 31325-36. https://doi.org/10.1074/jbc.M109.087122
- Sung YK, Kwack MH, Kim SR, Kim MK, Kim JC (2008). Transcriptional activation of CCN1 and CCN2, targets of canonical Wnt signal, by ascorbic acid 2-phosphate in human dermal papilla cells. J Dermatol Sci, 49, 256-9. https://doi.org/10.1016/j.jdermsci.2007.09.005
-
Tabatabai G, Moch H, Tritschler I, et al (2013). Integrin control of the transforming growth factor-
${\beta}$ pathway in glioblastoma. Brain, 136, 564-76. https://doi.org/10.1093/brain/aws351 - Todorovic V, Chen CC, Hay N, Lau LF (2005). The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol, 171, 559-68. https://doi.org/10.1083/jcb.200504015
- Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21, 178-85.
- Wang Y, Zhou BP (2013). Epithelial-mesenchymal Transition-a hallmark of breast cancer metastasis. Cancer Hallm, 1, 38-49. https://doi.org/10.1166/ch.2013.1004
- Xie D, Miller CW, O'Kelly J, et al (2001). Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem, 276, 14187-194.
- Xie JJ, Xu LY, Xie YM, et al (2011). Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells. Int J Mol Med, 27, 429-34.
- Yang J, Weinberg RA (2008). Epithelial-mesench;ymal transition: at the crossroads of development and tumor metastasis. Dev Cell, 14, 818-29. https://doi.org/10.1016/j.devcel.2008.05.009
- Zuo GW, Kohls CD, He BC, et al (2010). The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol, 25, 795-806.
Cited by
- Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4065
- Early Growth Response Protein-1 Involves in Transforming Growth factor-β1 Induced Epithelial-Mesenchymal Transition and Inhibits Migration of Non-Small-Cell Lung Cancer Cells vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4137
- Knockdown of Snail inhibits epithelial–mesenchymal transition of human laryngeal squamous cell carcinoma Hep-2 cells through the vitamin D receptor signaling pathway vol.95, pp.6, 2017, https://doi.org/10.1139/bcb-2017-0039
- KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition vol.13, pp.4, 2017, https://doi.org/10.3892/ol.2017.5734
- CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process vol.19, pp.1, 2019, https://doi.org/10.1186/s12885-019-5282-4